ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselICON Clinical Research (Switzerland) GmbH
ICON Clinical Research (Switzerland) GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The company ICON is a service provider to the pharmaceutical industry, focusing on clinical research, medical communication, and market access. The core activities include: * Clinical Research: Conducting clinical trials, including decentralized clinical trials, early-phase studies, and bioanalysis * Medical Communication: Creating medical content, such as publications, presentations, and marketing materials * Market Access: Supporting pharmaceutical companies in launching medicines, including health economics, outcomes research, and market research * Laboratory Services: Bioanalysis, biomarker development and analysis, as well as other laboratory services * Consulting: Strategic consulting for pharmaceutical companies in the areas of clinical research, market access, and medical communication The company also offers specialized services such as risk management, safety reporting, and regulatory affairs.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

ICON Clinical Research (Switzerland) GmbH

✓ Offered10
Clinical & Scientific Operations
Planning, management, conduct and analysis of Phase II to Phase IIIb studies; clinical data science, project management, logistics, IRT, pharmacovigilance, Medical Writing and regulatory support.
Decentralised Clinical Trial Solutions
End-to-end services, operating models and technology for patient-centric studies; Digital Health Technologies, In-Home Services, Concierge Services, Remote Monitoring and ICON Digital Platform.
Early Clinical
Early-phase development for first-in-human and proof-of-concept studies; Clinical Pharmacology, Global Clinical Research Units, Biometrics, Manufacturing & Pharmacy Services and early patient studies.
Laboratory Solutions
Laboratories for bioanalysis, central laboratory services and specialist or biomarker laboratories; PK, immunogenicity and biomarker analyses as well as harmonised laboratory data.
Site & Patient Solutions
Patient-centric services for recruitment, engagement and retention; Site Network, Patient Recruitment and Retention, Patient Insights, Site Portal and In-Home Services.
Strategic Solutions
Customised Functional Service Provision (FSP) with strategic outsourcing, organisational models, operational implementation and support in clinical monitoring, data management, biostatistics and other functions.
Regulatory Affairs
Strategic and operational regulatory consulting across the entire product lifecycle; Global Regulatory Strategy, Regulatory Project Services, CMC and Quality, Regulatory Operations, Labelling as well as Medical Devices & Diagnostics.
Real World Solutions
Real-world evidence, real-world study designs and evidence-value services; additional support for COA, translation, decentralised/hybrid/virtual trials, tokenisation and post-marketing pharmacovigilance.
Language Services
Translations, linguistic validations and translation technologies for clinical and medical content; including COA-related validation and multilingual study programmes.
Cardiac Safety Solutions
Cardiac safety monitoring across all development phases; ECG, blood pressure measurement, event monitoring, Holter monitoring, ECHO/MUGA and patient-oriented monitoring devices.
Trust & reputation

ranQ Trust Score of ICON Clinical Research (Switzerland) GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

ICON Clinical Research (Switzerland) GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
ICON Clinical Research (Switzerland) GmbH scores 86.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
ICON Clinical Research (Switzerland) GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
ICON Clinical Research (Switzerland) GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

ICON Clinical Research (Switzerland) GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once ICON Clinical Research (Switzerland) GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

ICON Clinical Research (Switzerland) GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank ICON Clinical Research (Switzerland) GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of ICON Clinical Research (Switzerland) GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Picassoplatz 8
4052 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-102.601.027
Founded
1998 · 28 years
Last commercial register change
February 24, 2023
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RA
    Rhenochem AG
    Basel
    DR
    Dr. Reddy's Laboratories SA
    Basel
    AS
    Azafaros Switzerland AG
    Basel
    EP
    Eumedica Pharmaceuticals AG
    Basel
    RC
    Roche Chemische Unternehmungen AG
    Basel
    TG
    Taysha Gene Therapies Switzerland GmbH
    Basel
    LS
    Lantheus Switzerland GmbH
    Basel
    NI
    Novartis International Pharmaceutical Investment AG
    Basel